Search details
1.
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.
Eur J Clin Invest
; 51(4): e13421, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33022756
2.
[Primary testicular lymphoma]. / Primární testikulární lymfomy.
Vnitr Lek
; 63(6): 415-422, 2017.
Article
in Cs
| MEDLINE | ID: mdl-28840738
3.
[Rituximab infusion-related toxicity in patients with chronic lymphocytic leukemia]. / Infuzní toxicita rituximabu u nemocných s chronickou lymfocytární leukemií.
Vnitr Lek
; 61(7-8): 626-32, 2015.
Article
in Cs
| MEDLINE | ID: mdl-26375688
4.
The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab.
Eur J Haematol
; 90(6): 479-85, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23506191
5.
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders.
Orphanet J Rare Dis
; 14(1): 9, 2019 01 09.
Article
in English
| MEDLINE | ID: mdl-30626415
6.
Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia.
Arch Med Sci
; 12(2): 421-7, 2016 Apr 01.
Article
in English
| MEDLINE | ID: mdl-27186190
7.
Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia.
Leuk Res
; 36(10): 1278-82, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22840362
Results
1 -
7
de 7
1
Next >
>>